Fennec Pharmaceuticals Income Statement (2010-2026) | FENC

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Jun2026
Revenue & cost
Revenue (Quarter)								1.68M	3.33M	6.51M	9.73M	25.38M	7.26M	6.97M	7.92M	8.75M	9.65M	12.46M	13.78M	17.87M
Cost of Revenue (Quarter)								0.10M	0.15M	0.33M	0.69M	0.55M	0.61M	1.36M	0.67M	0.37M	0.97M	0.66M	1.76M	0.72M
Gross Profit (Quarter)								1.58M	3.18M	6.18M	9.05M	24.83M	6.65M	5.62M	7.26M	8.38M	8.69M	11.80M	12.01M	17.15M
Operating items
Research & Development (Quarter)	0.80M	1.24M	0.52M	1.44M	1.13M	0.85M	0.12M	0.00M	0.01M	3.38M	0.03M	0.00M	4.67M	4.60M	3.94M	2.95M	0.11M	5.21M	18.39M	10.66M
Selling, General & Administrative (Quarter)	3.12M	2.93M	3.68M	2.11M	3.88M	7.05M	4.68M	4.32M	5.50M	3.81M	6.97M	5.87M	6.86M	6.12M	4.20M	6.14M	6.96M	6.75M	8.44M	4.64M
Other Operating Expenses (Quarter)					-10.02M		2.79M	2.63M	2.49M	0.34M	4.55M	5.76M	0.77M	1.45M	0.72M	0.47M	5.32M	0.69M	-10.50M	0.84M
Operating Expenses (Quarter)	3.92M	4.17M	4.21M	3.55M	-5.01M	7.90M	7.58M	6.95M	7.99M	7.53M	11.55M	11.63M	12.30M	12.18M	8.86M	9.56M	12.38M	12.65M	16.33M	16.14M
Operating Income (Quarter)	-3.92M	-4.17M	-4.21M	-3.55M	-5.01M	-7.90M	-6.13M	-5.27M	-4.67M	-1.02M	-1.82M	13.74M	-5.04M	-5.20M	-0.93M	-0.81M	-2.73M	-0.19M	-2.55M	1.74M
EBIT (Quarter)	-3.92M	-4.17M	-4.21M	-3.55M	-5.01M	-7.90M	-6.13M	-5.27M	-4.67M	-1.02M	-1.82M	13.74M	-5.04M	-5.20M	-0.93M	-0.81M	-2.73M	-0.19M	-2.55M	1.74M
Non-operating items
Interest & Investment Income (Quarter)	0.01M	0.01M	0.01M	0.01M	0.01M	0.02M	0.15M	0.11M	0.12M	0.10M	0.12M	0.20M	0.57M	0.52M	0.40M	0.24M	0.17M	0.15M	0.23M	0.29M
Other Non Operating Income (Quarter)	-0.00M	-0.00M	-0.00M	-0.00M	0.00M	-0.00M	-0.00M	0.01M	0.01M	-0.01M	0.00M	-0.04M	-0.02M		-0.03M	0.01M	0.02M	-0.00M	-2.05M	-0.01M
Non Operating Income (Quarter)	-0.08M	-0.01M	-0.22M	-0.15M	-0.06M	-0.19M	-0.72M	-0.78M	-0.78M	-0.85M	-0.86M	-0.91M	-0.51M	-0.53M	-0.69M	-0.36M	-0.42M	-0.45M	-2.13M	0.28M
Net income details
EBT (Quarter)	-3.96M	-4.21M	-4.26M	-3.60M	-5.06M	-8.05M	-6.73M	-5.96M	-5.38M	-1.77M	-2.62M	12.91M	-5.51M	-5.71M	-1.25M	-1.16M	-3.15M	-0.62M	-4.71M	2.02M
Tax Provisions (Quarter)																				0.04M
Profit After Tax (Quarter)																				1.97M
Income from Non-Controlling Interests (Quarter)
Income from Continuing Operations (Quarter)																				1.97M
Consolidated Net Income (Quarter)																				1.97M
Income towards Parent Company (Quarter)																				1.97M
Net Income towards Common Stockholders (Quarter)																				1.97M
Additional items
EPS (Basic) (Quarter)																				0.06
EPS (Diluted) (Quarter)																				0.05
Shares Outstanding (Quarter)																				34.55M
Shares Outstanding (Diluted) (Quarter)																				36.43M
Shares Outstanding (Entity) (Quarter)																				35.03M
EBITDA (Quarter)																				1.74M
Interest Expenses (Quarter)																				0.00M
Tax Rate (Quarter)																				2.08%

Research Tools

Datasets

Plans

Developers

Fennec Pharmaceuticals Income Statement (2010-2026) | FENC

Research Tools

Datasets

Plans

Developers

Fennec Pharmaceuticals Income Statement (2010-2026) | FENC

Create an account

Sign In

Reset Password